CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 5,660	$ 12,694
Short-term investments	718	498
Accounts receivable (net of allowance for doubtful accounts of $86 in 2023 and $72 in 2022)	11,030	9,450
Inventories (excludes inventories of $3,220 in 2023 and $2,938 in 2022 classified in Other assets - see Note 7)	5,930	5,911
Other current assets	6,639	7,169
Total current assets	29,977	35,722
Investments	1,214	1,015
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,432 in 2023 and $17,985 in 2022	22,231	21,422
Goodwill	21,195	21,204
Other Intangibles, Net	19,665	20,269
Other Assets	10,187	9,528
Total Assets	104,469	109,160
Current Liabilities
Loans payable and current portion of long-term debt	2,839	1,946
Trade accounts payable	3,442	4,264
Accrued and other current liabilities	13,747	14,159
Income taxes payable	1,489	1,986
Dividends payable	1,877	1,884
Total current liabilities	23,394	24,239
Long-Term Debt	34,072	28,745
Deferred Income Taxes	996	1,795
Other Noncurrent Liabilities	7,265	8,323
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022	1,788	1,788
Other paid-in capital	44,219	44,379
Retained earnings	54,198	61,081
Accumulated other comprehensive loss	(4,900)	(4,768)
Stockholders' equity before deduction for treasury stock	95,305	102,480
Less treasury stock, at cost: 1,037,678,033 shares in 2023 and 1,039,269,638 shares in 2022	56,612	56,489
Total Merck & Co., Inc. stockholders’ equity	38,693	45,991
Noncontrolling Interests	49	67
Total equity	38,742	46,058
Liabilities and Equity	$ 104,469	$ 109,160